Skip to content

Serine/threonine-protein kinase MRCK beta (CDC42BPB)

Homo sapiens — UniProt Q9Y5S2

Gene: CDC42BPBHomo sapiensSwissProt reviewed

Data last refreshed: (UniProt release unknown)

Key facts

Serine/threonine-protein kinase MRCK beta (CDC42BPB) is a protein from Homo sapiens identified by UniProt accession Q9Y5S2, 1711 residues long. MolForge cross-references it against 4 known binders and 44 disease associations.

  • UniProt accession: Q9Y5S2; gene symbol CDC42BPB.
  • Organism: Homo sapiens.
  • Length: 1711 amino acids.
  • Top disease associations (Open Targets): Chilton-Okur-Chung neurodevelopmental syndrome, neurodegenerative disease and genetic disorder.
  • 3D structure: AlphaFold model available.

Target properties

Protein nameSerine/threonine-protein kinase MRCK beta
UniProt accessionQ9Y5S2
GeneCDC42BPB
OrganismHomo sapiens
Length1711 residues
Molecular weight—
EC numbers—
Target class—
Subcellular location—
Keywords—

Druggability

Target tractability assessment (Open Targets + pocket analysis). No approved drug

Druggability tierMEDIUM
Druggability score—
Pocket score—
Max clinical phase—

Disease associations (44)

Diseases linked to this target (Open Targets).

  • Chilton-Okur-Chung neurodevelopmental syndrome · score 0.70
  • neurodegenerative disease · score 0.46
  • genetic disorder · score 0.41
  • Neurodevelopmental disorder · score 0.31
  • autism spectrum disorder · score 0.30
  • Intellectual disability · score 0.23
  • Global developmental delay · score 0.23
  • Autistic behavior · score 0.23
  • Seizure · score 0.23
  • Atypical behavior · score 0.23

3D Structure (1)

Experimental (PDB) and predicted (AlphaFold) structures for this protein.

StructureSourceMethodMean pLDDTResolution (Å)
AF-Q9Y5S2-F1alphafoldPREDICTED75.79—

Experimental structures are not indexed in MolForge yet — search RCSB PDB for Q9Y5S2.

Amino-acid sequence (1711 residues)

MSAKVRLKKL EQLLLDGPWR NESALSVETL LDVLVCLYTE CSHSALRRDK YVAEFLEWAK PFTQLVKEMQ LHREDFEIIK VIGRGAFGEV AVVKMKNTER IYAMKILNKW EMLKRAETAC FREERDVLVN GDCQWITALH YAFQDENHLY LVMDYYVGGD LLTLLSKFED KLPEDMARFY IGEMVLAIDS IHQLHYVHRD IKPDNVLLDV NGHIRLADFG SCLKMNDDGT VQSSVAVGTP DYISPEILQA MEDGMGKYGP ECDWWSLGVC MYEMLYGETP FYAESLVETY GKIMNHEERF QFPSHVTDVS EEAKDLIQRL ICSRERRLGQ NGIEDFKKHA FFEGLNWENI RNLEAPYIPD VSSPSDTSNF DVDDDVLRNT EILPPGSHTG FSGLHLPFIG FTFTTESCFS DRGSLKSIMQ SNTLTKDEDV QRDLEHSLQM EAYERRIRRL EQEKLELSRK LQESTQTVQS LHGSSRALSN SNRDKEIKKL NEEIERLKNK IADSNRLERQ LEDTVALRQE REDSTQRLRG LEKQHRVVRQ EKEELHKQLV EASERLKSQA KELKDAHQQR KLALQEFSEL NERMAELRAQ KQKVSRQLRD KEEEMEVATQ KVDAMRQEMR RAEKLRKELE AQLDDAVAEA SKERKLREHS ENFCKQMESE LEALKVKQGG RGAGATLEHQ QEISKIKSEL EKKVLFYEEE LVRREASHVL EVKNVKKEVH DSESHQLALQ KEILMLKDKL EKSKRERHNE MEEAVGTIKD KYERERAMLF DENKKLTAEN EKLCSFVDKL TAQNRQLEDE LQDLAAKKES VAHWEAQIAE IIQWVSDEKD ARGYLQALAS KMTEELEALR SSSLGSRTLD PLWKVRRSQK LDMSARLELQ SALEAEIRAK QLVQEELRKV KDANLTLESK LKDSEAKNRE LLEEMEILKK KMEEKFRADT GLKLPDFQDS IFEYFNTAPL AHDLTFRTSS ASEQETQAPK PEASPSMSVA ASEQQEDMAR PPQRPSAVPL PTTQALALAG PKPKAHQFSI KSFSSPTQCS HCTSLMVGLI RQGYACEVCS FACHVSCKDG APQVCPIPPE QSKRPLGVDV QRGIGTAYKG HVKVPKPTGV KKGWQRAYAV VCDCKLFLYD LPEGKSTQPG VIASQVLDLR DDEFSVSSVL ASDVIHATRR DIPCIFRVTA SLLGAPSKTS SLLILTENEN EKRKWVGILE GLQSILHKNR LRNQVVHVPL EAYDSSLPLI KAILTAAIVD ADRIAVGLEE GLYVIEVTRD VIVRAADCKK VHQIELAPRE KIVILLCGRN HHVHLYPWSS LDGAEGSFDI KLPETKGCQL MATATLKRNS GTCLFVAVKR LILCYEIQRT KPFHRKFNEI VAPGSVQCLA VLRDRLCVGY PSGFCLLSIQ GDGQPLNLVN PNDPSLAFLS QQSFDALCAV ELESEEYLLC FSHMGLYVDP QGRRARAQEL MWPAAPVACS CSPTHVTVYS EYGVDVFDVR TMEWVQTIGL RRIRPLNSEG TLNLLNCEPP RLIYFKSKFS GAVLNVPDTS DNSKKQMLRT RSKRRFVFKV PEEERLQQRR EMLRDPELRS KMISNPTNFN HVAHMGPGDG MQVLMDLPLS AVPPSQEERP GPAPTNLARQ PPSRNKPYIS WPSSGGSEPS VTVPLRSMSD PDQDFDKEPD SDSTKHSTPS NSSNPSGPPS PNSPHRSQLP LEGLEQPACD T

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

Which diseases are associated with CDC42BPB?

The strongest Open Targets associations for CDC42BPB are Chilton-Okur-Chung neurodevelopmental syndrome, neurodegenerative disease, genetic disorder, Neurodevelopmental disorder and autism spectrum disorder.

How long is the CDC42BPB protein?

The Homo sapiens CDC42BPB protein (UniProt Q9Y5S2) is 1711 amino acids long.

Browse: Targets: C · all protein targets A–Z · drugs A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Explore Serine/threonine-protein kinase MRCK beta with MolForge

Find binders, run structure-based screening, and map this target across diseases and approved drugs with our AI-powered platform.

Browse all targets

Quick facts

UniProtQ9Y5S2
GeneCDC42BPB
OrganismHomo sapiens
Length1711
Binders4
Diseases44
View on UniProt